Cases & Deals

Citigroup Global Markets and Natixis complete €80 million rights offering and related private placement by Genfit

Clients Natixis

Jones Day advised Citigroup Global Markets Limited and Natixis in connection with the €80 million capital increase by Genfit, a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The capital increase was done in two phases:  a private placement reserved for the benefit of a specific category of investors for €34 million and a rights offering of approximately €45 million.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.